These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

461 related items for PubMed ID: 21803090

  • 21. Intranasal Protollin/F1-V vaccine elicits respiratory and serum antibody responses and protects mice against lethal aerosolized plague infection.
    Jones T, Adamovicz JJ, Cyr SL, Bolt CR, Bellerose N, Pitt LM, Lowell GH, Burt DS.
    Vaccine; 2006 Mar 06; 24(10):1625-32. PubMed ID: 16243411
    [Abstract] [Full Text] [Related]

  • 22. Targeting of LcrV virulence protein from Yersinia pestis to dendritic cells protects mice against pneumonic plague.
    Do Y, Koh H, Park CG, Dudziak D, Seo P, Mehandru S, Choi JH, Cheong C, Park S, Perlin DS, Powell BS, Steinman RM.
    Eur J Immunol; 2010 Oct 06; 40(10):2791-6. PubMed ID: 20812236
    [Abstract] [Full Text] [Related]

  • 23. Prospects for new plague vaccines.
    Feodorova VA, Corbel MJ.
    Expert Rev Vaccines; 2009 Dec 06; 8(12):1721-38. PubMed ID: 19943765
    [Abstract] [Full Text] [Related]

  • 24. Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates.
    Williamson ED, Flick-Smith HC, Waters E, Miller J, Hodgson I, Le Butt CS, Hill J.
    Microb Pathog; 2007 Jan 06; 42(1):11-21. PubMed ID: 17107769
    [Abstract] [Full Text] [Related]

  • 25. Novel CTL epitopes identified through a Y. pestis proteome-wide analysis in the search for vaccine candidates against plague.
    Zvi A, Rotem S, Zauberman A, Elia U, Aftalion M, Bar-Haim E, Mamroud E, Cohen O.
    Vaccine; 2017 Oct 20; 35(44):5995-6006. PubMed ID: 28606812
    [Abstract] [Full Text] [Related]

  • 26. Recombinant (F1+V) vaccine protects cynomolgus macaques against pneumonic plague.
    Williamson ED, Packer PJ, Waters EL, Simpson AJ, Dyer D, Hartings J, Twenhafel N, Pitt ML.
    Vaccine; 2011 Jun 24; 29(29-30):4771-7. PubMed ID: 21570437
    [Abstract] [Full Text] [Related]

  • 27. [Evaluation of immunization protection efficacy of plague subunit vaccine].
    Zhang QW, Qi ZZ, Xin YQ, Yang YH, Wu HL, Yang HQ, Feng JP, Jin X, Cui BZ, Wang T, Wu BC, Qiu YF, Wang W, Guo ZB, Wang ZY, Yang RF, Wang H, Wang XY.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Sep 24; 43(9):785-8. PubMed ID: 20137561
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.
    FEMS Immunol Med Microbiol; 2003 Oct 15; 38(3):215-29. PubMed ID: 14522457
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Humoral and cellular immune responses to Yersinia pestis infection in long-term recovered plague patients.
    Li B, Du C, Zhou L, Bi Y, Wang X, Wen L, Guo Z, Song Z, Yang R.
    Clin Vaccine Immunol; 2012 Feb 15; 19(2):228-34. PubMed ID: 22190397
    [Abstract] [Full Text] [Related]

  • 32. Single-dose intranasal subunit vaccine rapidly clears secondary sepsis in a high-dose pneumonic plague infection.
    D'Arco C, McCormick AA, Arnaboldi PM.
    Vaccine; 2021 Mar 01; 39(9):1435-1444. PubMed ID: 33531196
    [Abstract] [Full Text] [Related]

  • 33. Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.
    DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, Schneewind O.
    Infect Immun; 2006 Aug 01; 74(8):4910-4. PubMed ID: 16861680
    [Abstract] [Full Text] [Related]

  • 34. Complete Protection Against Yersinia pestis in BALB/c Mouse Model Elicited by Immunization With Inhalable Formulations of rF1-V10 Fusion Protein via Aerosolized Intratracheal Inoculation.
    Zhang W, Song X, Zhai L, Guo J, Zheng X, Zhang L, Lv M, Hu L, Zhou D, Xiong X, Yang W.
    Front Immunol; 2022 Aug 01; 13():793382. PubMed ID: 35154110
    [Abstract] [Full Text] [Related]

  • 35. Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.
    Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM.
    FEMS Immunol Med Microbiol; 2012 Aug 01; 65(3):505-9. PubMed ID: 22515653
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of CD4+/CD8+ T-cell expression and IFN-γ, perforin secretion for B-T constructs of F1 and V antigens of Yersinia pestis.
    Gupta G, Ali R, Khan AA, Rao DN.
    Int Immunopharmacol; 2012 Jan 01; 12(1):64-73. PubMed ID: 22094541
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A Yersinia pestis YscN ATPase mutant functions as a live attenuated vaccine against bubonic plague in mice.
    Bozue J, Cote CK, Webster W, Bassett A, Tobery S, Little S, Swietnicki W.
    FEMS Microbiol Lett; 2012 Jul 01; 332(2):113-21. PubMed ID: 22537022
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.